Bioharvest Sciences Inc 8MV0.MU is expected to report resultson March 31 for the period ending December 31 2024
The Vancouver British Columbia-based company is expected to report revenue of $7.238 million, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Bioharvest Sciences Inc is for a loss of 12 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The average consensus recommendation for the food processing peer group is also "Buy".
Wall Street's median 12-month price target for Bioharvest Sciences Inc is $14.00, above its last closing price of $6.45.
This summary was machine generated March 28 at 20:16 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)